Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT05155592
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of non-infectious uveitis
* nflammation was controlled for 6 months after drug remission was achieved using Adalimumab in combination with immunosuppressant therapy
* Family members and patients who are willing to stop should agree and accept relevant examinations
* The informed consent is read and signed by the patient or a legally authorized represent
Exclusion Criteria:
* Unwilling to sign informed consent
* There is systemic autoimmune disease uncontrolled situation
* Patients who may require surgery in the near future
* Vision meets the standards of low vision and blindness
* Silicone oil or gas filling after vitreous surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
70 Years
Study:
NCT05155592
Study Brief:
Protocol Section:
NCT05155592